Bluejay Diagnostics, Inc.
NASDAQ Capital MarketTotal Valuation
Bluejay Diagnostics, Inc. carries a market capitalization of 2.05M, placing it among publicly traded companies globally. Its enterprise value stands at -2.53M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.05M |
| Enterprise Value | -2.53M |
Share Statistics
Bluejay Diagnostics, Inc. currently has 1.03M shares outstanding.
| Shares Outstanding | 1.03M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.02 |
| P/TBV Ratio | 0.25 |
| P/FCF Ratio | -0.17 |
| P/OCF Ratio | -0.16 |
Financial Position
Bluejay Diagnostics, Inc. maintains a current ratio of 2.81, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.32, indicating elevated leverage, while an interest coverage ratio of -11,222.56 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.81 |
| Quick Ratio | 2.61 |
| Debt / Equity | 2.32 |
| Debt / EBITDA | -0.01 |
| Interest Coverage | -11,222.56 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -126.94 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Bluejay Diagnostics, Inc.'s stock has declined approximately -36.6573% over the past 52 weeks. The 50-day moving average sits at 1.95, while the 200-day moving average is 4.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.6573% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 4.20 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -6.83M, while operating income came in at -7.00M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -7.00M |
| Pretax Income | -6.90M |
| Net Income | -6.90M |
| EBITDA | -6.83M |
| EBIT | -7.00M |
| Earnings Per Share (EPS) | -12.01 |
Balance Sheet
Bluejay Diagnostics, Inc. holds 3.68M in cash and equivalents against 97,032.00 in total debt, resulting in a net debt position of -3.68M. Total book value stands at -43.44M, with working capital of 2.55M providing operational flexibility.
| Cash & Cash Equivalents | 3.68M |
| Total Debt | 97,032.00 |
| Net Debt | -3.68M |
| Equity (Book Value) | -43.44M |
| Book Value Per Share | -75.54 |
| Working Capital | 2.55M |
Cash Flow
Bluejay Diagnostics, Inc. produced -6.46M in operating cash flow over the past twelve months. After subtracting -192,724.00 in capital expenditures, free cash flow totaled -6.65M - equivalent to -11.57 per share.
| Operating Cash Flow | -6.46M |
| Capital Expenditures | -192,724.00 |
| Free Cash Flow | -6.65M |
| FCF Per Share | -11.57 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -681.95 |
| FCF Yield | -592.15 |
Stock Splits
Bluejay Diagnostics, Inc.'s most recent stock split took place on January 29, 2026 with a 4:1 split ratio.
| Last Split Date | 1/29/2026 |
| Split Ratio | 4:1 |
Scores
Bluejay Diagnostics, Inc. posts an Altman Z-Score of -13.99, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -13.99 |